Papers of the Week

< BACK TO ARCHIVE

DATE PUBLISHED:
2019 Oct 08

JOURNAL:
Vaccine

PUBMED:
http://www.ncbi.nlm.nih.gov/pubmed/31537443?dopt=Abstract

Volume:
37

ISSUE:
43

Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials.

Authors

Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials.

Willer DO, Oostvogels L, Cunningham AL, Gervais P, Gorfinkel I, Hyung Kim J, Talarico C, Wascotte V, Zahaf T, Colindres R, Schuind A

Vaccine. 2019 Oct 08; 37(43):6262-6267.

PMID: 31537443.

Abstract

Herpes zoster (HZ) risk appears to vary by sex and geographic ancestry/ethnicity.

Read This Paper